Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.
Saved in:
| Title: | Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. |
|---|---|
| Authors: | Hernandez LD; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Racine F; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Xiao L; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., DiNunzio E; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Hairston N; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Sheth PR; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Murgolo NJ; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Therien AG; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA alex_therien@merck.com. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Feb; Vol. 59 (2), pp. 1052-60. Date of Electronic Publication: 2014 Dec 01. |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25451052 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hernandez+LD%22">Hernandez LD</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Racine+F%22">Racine F</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+L%22">Xiao L</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22DiNunzio+E%22">DiNunzio E</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hairston+N%22">Hairston N</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Sheth+PR%22">Sheth PR</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Murgolo+NJ%22">Murgolo NJ</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Therien+AG%22">Therien AG</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA alex&#95;therien@merck.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2015 Feb; Vol. 59 (2), pp. 1052-60. <i>Date of Electronic Publication: </i>2014 Dec 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25451052 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1128/AAC.04433-14 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1052 Titles: – TitleFull: Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hernandez LD – PersonEntity: Name: NameFull: Racine F – PersonEntity: Name: NameFull: Xiao L – PersonEntity: Name: NameFull: DiNunzio E – PersonEntity: Name: NameFull: Hairston N – PersonEntity: Name: NameFull: Sheth PR – PersonEntity: Name: NameFull: Murgolo NJ – PersonEntity: Name: NameFull: Therien AG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2015 Feb Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1098-6596 Numbering: – Type: volume Value: 59 – Type: issue Value: 2 Titles: – TitleFull: Antimicrobial agents and chemotherapy Type: main |
| ResultId | 1 |